Your Complete Guide to Global Clinical Research and GCP Compliance
Aligning Plain-Language Summaries & Layperson Results With ICH, GCP and Transparency Regulations In the evolving landscape of clinical research, ensuring clear communication of trial results is paramount. Regulatory bodies such as the FDA, EMA, and MHRA emphasize the importance of transparency, specifically through the use of plain-language summaries and layperson results. This article aims to…
Plain-Language Summaries & Layperson Results Playbook for High-Profile and Late-Phase Trials Plain-Language Summaries & Layperson Results Playbook for High-Profile and Late-Phase Trials Within the landscape of clinical trials, particularly in late-phase development and high-profile studies, the emphasis on transparency and effective communication has never been more critical. Among the key components of regulatory compliance is…
Protocol Synopsis & Full Protocol in Practice: Step-by-Step Guide for Sponsors, CROs and Sites This comprehensive guide provides clinical research professionals with a clear understanding of the development, preparation, and implementation of protocol synopses and full protocols in clinical trials. Primary emphasis is placed on ensuring compliance with the International Conference on Harmonisation’s Good Clinical…
Plain-Language Summaries & Layperson Results in Practice: Step-by-Step Guide for Sponsors and CROs Plain-Language Summaries & Layperson Results in Practice: Step-by-Step Guide for Sponsors and CROs Clinical trials are integral to advancing medical knowledge and improving patient outcomes. As part of an increasing emphasis on transparency in clinical research, the need for plain-language summaries (PLS)…
Common Pitfalls in Plain-Language Summaries & Layperson Results—and How to Avoid Costly Findings As clinical trials evolve, so does the necessity for transparency in conveying results to a broader audience. Plain-language summaries and layperson results provide crucial insights to stakeholders, including patients and the public, facilitating a better understanding of clinical research outcomes. However, crafting…
How to Design Protocol Synopsis & Full Protocol That Aligns With GCP, ICH and Regulatory Guidance Designing Protocol Synopsis & Full Protocols in Compliance with GCP, ICH, and Regulatory Guidance In conducting clinical trials, the integrity and success of the study hinge significantly on the detailed design of both the protocol synopsis and the full…
Plain-Language Summaries & Layperson Results: Compliance Strategy for US, EU and UK Clinical Programs Clinical trials are a critical component in the development of new therapies, particularly in complex therapeutic areas such as oncology. As clinical research continues to evolve, regulations surrounding clinical trial transparency have become increasingly stringent. This article provides a comprehensive, step-by-step…
How to Design Plain-Language Summaries & Layperson Results That Meets FDA, EMA and MHRA Expectations How to Design Plain-Language Summaries & Layperson Results That Meets FDA, EMA and MHRA Expectations In the complex landscape of clinical trials, the importance of clear and accessible communication cannot be overstated. Regulatory authorities such as the FDA, EMA, and…
Protocol Synopsis & Full Protocol: Inspection-Ready Standards for US, UK and EU Clinical Trials Introduction to Clinical Trials Protocols Clinical trials are foundational to the advancement of medical knowledge and therapeutics. Standardized protocols are essential to ensure both the integrity of the research and compliance with regulatory requirements. The protocol serves as a blueprint for…
Using Results Posting & Timelines to Support Publications, HTA and Market Access In the current regulatory environment, the requirements surrounding clinical trial transparency and disclosure are paramount. This detailed tutorial serves as a comprehensive guide for clinical operations, regulatory affairs, and medical affairs professionals engaged in clinical trials, particularly focusing on the posting of results,…
Read More “Using Results Posting & Timelines to Support Publications, HTA and Market Access” »
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.